Literature DB >> 11263784

Variations in susceptibility to proteoglycan-induced arthritis and spondylitis among C3H substrains of mice: evidence of genetically acquired resistance to autoimmune disease.

T T Glant1, T Bárdos, C Vermes, R Chandrasekaran, J C Valdéz, J M Otto, D Gerard, S Velins, G Lovász, J Zhang, K Mikecz, A Finnegan.   

Abstract

OBJECTIVE: To identify and screen the level of arthritis susceptibility in C3H murine strains known to be resistant to proteoglycan (aggrecan)-induced arthritis, and to measure and correlate various immunologic and inflammatory parameters with susceptibility to either arthritis or spondylitis in various C3H substrains.
METHODS: Mice of 10 C3H substrains (subcolonies) were immunized with cartilage proteoglycan (aggrecan) for induction of arthritis. Animals were assessed for clinical symptoms, and the peripheral joints and spine were studied by histologic methods. Proteoglycan-specific T cell responses (T cell proliferation and production of interleukin-2 [IL-2], interferon-y, and IL-4) and the B cell response to lipopolysaccharide (LPS) were measured in spleen cell cultures. Serum levels of heteroantibodies and autoantibodies as well as various cytokines (IL-6, IL-10, IL-12, and tumor necrosis factor alpha) and soluble CD44 were determined by enzyme-linked immunosorbent assay.
RESULTS: Immunization with cartilage proteoglycan induced severe arthritis in the C3H/HeJCr substrain (95-100% incidence), whereas the original parent mice of the C3H/HeJ colony were resistant to proteoglycan (aggrecan)-induced arthritis. Furthermore, the progressive polyarthritis that is characteristic in susceptible C3H/HeJCr mice was accompanied by progressive inflammation around the spine. In subsequent experiments, 10 different C3H colonies with largely identical genetic backgrounds (all originating from the National Institutes of Health or Jackson Laboratory) exhibited extreme differences in susceptibility. Although none of the laboratory findings, including LPS hyporesponsiveness, immunologic parameters, and inflammatory markers, showed a correlation with susceptibility or resistance in the C3H/HeJCr and C3H/HeJ substrains, respectively, significant differences were found when all arthritic C3H mice were compared with all nonarthritic animals, regardless of their substrain origin.
CONCLUSION: Because many of the C3H substrains lost arthritis susceptibility or acquired resistance, our results suggest that a preferred site for a mutation(s) in a gene(s) in a relatively upstream position of the inflammatory cascade is present. This is the first autoimmune model that exhibits extreme differences in arthritis susceptibility in the same murine strain, and is therefore a valuable tool for identification of arthritis-susceptible (or arthritis-suppressive) genes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11263784     DOI: 10.1002/1529-0131(200103)44:3<682::AID-ANR118>3.0.CO;2-E

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  17 in total

1.  Disease-promoting and -protective genomic loci on mouse chromosomes 3 and 19 control the incidence and severity of autoimmune arthritis.

Authors:  T T Glant; V A Adarichev; F Boldizsar; T Besenyei; A Laszlo; K Mikecz; T A Rauch
Journal:  Genes Immun       Date:  2012-03-08       Impact factor: 2.676

Review 2.  Experimental spondyloarthropathies: animal models of ankylosing spondylitis.

Authors:  Vyacheslav A Adarichev; Tibor T Glant
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

3.  Anti-inflammatory and chondroprotective effect of TSG-6 (tumor necrosis factor-alpha-stimulated gene-6) in murine models of experimental arthritis.

Authors:  T Bárdos; R V Kamath; K Mikecz; T T Glant
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

Review 4.  Animal models of ankylosing spondylitis.

Authors:  Yiping Zhang; Shuilang Shi; Christina Ciurli; A Robin Poole
Journal:  Curr Rheumatol Rep       Date:  2002-12       Impact factor: 4.592

5.  Proteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis.

Authors:  Tibor T Glant; Marianna Radacs; Gyorgy Nagyeri; Katalin Olasz; Anna Laszlo; Ferenc Boldizsar; Akos Hegyi; Alison Finnegan; Katalin Mikecz
Journal:  Arthritis Rheum       Date:  2011-05

6.  Continuous nasal administration of antigen is critical to maintain tolerance in adoptively transferred autoimmune arthritis in SCID mice.

Authors:  T Bárdos; M Czipri; C Vermes; J Zhang; K Mikecz; T T Glant
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

Review 7.  Influence of genetic background on genetically engineered mouse phenotypes.

Authors:  Thomas Doetschman
Journal:  Methods Mol Biol       Date:  2009

8.  Substrain-specific differences in survival and osteonecrosis incidence in a mouse model.

Authors:  Jitesh D Kawedia; Laura Janke; Amy J Funk; Laura B Ramsey; Chengcheng Liu; David Jenkins; Kelli L Boyd; Mary V Relling
Journal:  Comp Med       Date:  2012-12       Impact factor: 0.982

9.  BALB/c mice genetically susceptible to proteoglycan-induced arthritis and spondylitis show colony-dependent differences in disease penetrance.

Authors:  Balint Farkas; Ferenc Boldizsar; Oktavia Tarjanyi; Anna Laszlo; Simon M Lin; Gabor Hutas; Beata Tryniszewska; Aaron Mangold; Gyorgy Nagyeri; Holly L Rosenzweig; Alison Finnegan; Katalin Mikecz; Tibor T Glant
Journal:  Arthritis Res Ther       Date:  2009-02-16       Impact factor: 5.156

Review 10.  The value of animal models in predicting genetic susceptibility to complex diseases such as rheumatoid arthritis.

Authors:  Emma Ahlqvist; Malin Hultqvist; Rikard Holmdahl
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.